Department of Prosthodontics, Hebei Key Laboratory of Stomatology, Hebei Clinical Research Center for Oral Diseases, School and Hospital of Stomatology, Hebei Medical University, Shijiazhuang, 050017, PR China.
Shanghai University of Medicine and Health Sciences, Shanghai 201318, PR China.
Biomater Sci. 2023 Sep 12;11(18):6357-6372. doi: 10.1039/d3bm00805c.
Maxillofacial bone defect repair and regeneration remains a tremendous challenge in the field of stomatology. However, the limited osteoinductivity of artificial materials and the high cost of bioactive agents restrain their clinical translation. This study aimed to construct an economical and efficient concentrated growth factor/mesoporous bioactive glass (CGF/MBG) composite scaffold for bone regeneration. The biochemical composition and biological effects of different forms of CGFs were systematically compared, and the results showed that CGF-conditioned medium effectively promoted proliferation, migration and osteogenesis of allogenic BMSCs. Gel phase CGF (gpCGF) exhibited superior bioactivity and osteoinductivity to liquid phase CGF (lpCGF) and liquid/gel mixed phase CGF (lgpCGF), and was further applied to construct CGF/MBG scaffolds. studies demonstrated that co-culture with gpCGF-conditioned medium further enhanced the biocompatibility of MBG, increasing cell adhesion and proliferation on the scaffold. On this basis, two compositing approaches to construct the scaffold by fibrin gel formation (CGF/FG/MBG) and freeze-drying (fdCGF/MBG) were applied, and the biological efficacy of CGFs was compared . In a rabbit mandibular defect model, higher osteogenic efficiency in bone regeneration of CGF/FG/MBG composite scaffolds was proved, compared with fdCGF/MBG. Taken together, the CGF/FG/MBG composite scaffold is expected to be an efficient bone repairing therapy for clinical translation, and the CGF-composited scaffold using gpCGF and the fibrin gel formation method is a promising way to enhance the bioactivity and osteoinductivity of current clinical bone repairing materials, providing new thoughts on the development of future orthopedic biomaterials.
颌面骨缺损的修复和再生仍然是口腔医学领域的巨大挑战。然而,人工材料的成骨诱导能力有限和生物活性剂的高成本限制了它们的临床转化。本研究旨在构建一种经济高效的浓缩生长因子/介孔生物活性玻璃(CGF/MBG)复合支架用于骨再生。系统比较了不同形式的 CGF 的生化组成和生物学效应,结果表明 CGF 条件培养基有效促进了同种异体 BMSCs 的增殖、迁移和成骨分化。凝胶相 CGF(gpCGF)比液相 CGF(lpCGF)和液/凝胶混合相 CGF(lgpCGF)具有更好的生物活性和成骨诱导性,进一步应用于构建 CGF/MBG 支架。研究表明,与 gpCGF 条件培养基共培养进一步增强了 MBG 的生物相容性,增加了细胞在支架上的黏附与增殖。在此基础上,应用纤维蛋白凝胶形成(CGF/FG/MBG)和冷冻干燥(fdCGF/MBG)两种复合方法构建支架,并比较了 CGF 的生物学功效。在兔下颌骨缺损模型中,证明 CGF/FG/MBG 复合支架的骨再生具有更高的成骨效率,优于 fdCGF/MBG。综上所述,CGF/FG/MBG 复合支架有望成为一种高效的临床转化骨修复治疗方法,使用 gpCGF 和纤维蛋白凝胶形成方法构建的 CGF 复合支架是增强当前临床骨修复材料生物活性和成骨诱导性的一种有前途的方法,为未来骨科生物材料的发展提供了新的思路。